Dabigatran versus Warfarin in Patients with Atrial FibrillationStuart J. Connolly, Lars Wallentin, Michael D. Ezekowitz et al.|New England Journal of Medicine|2009Cited by 11.2k
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsMarcus Flather, Eugene Braunwald, Salim Yusuf et al.|The Lancet|2000Cited by 1.6k
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Stuart J. Connolly, Salim Yusuf et al.|The Lancet|2010Cited by 1k
Aspirin in Patients Undergoing Noncardiac SurgeryP.J. Devereaux, Salim Yusuf, Marko Mrkobrada et al.|New England Journal of Medicine|2014Cited by 934
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeStuart J. Connolly, Salim Yusuf, Janice Pogue et al.|Circulation|2008Cited by 873